Established in May 2025, Shenzhen Shenyi Technology Co., Ltd. is at the forefront of cross-innovation between AI and brain science. The company is dedicated to the research and development of brain function monitoring and intervention products, specifically targeting brain disorders such as sleep disturbances and depression. Its core team comprises seasoned professionals from esteemed companies including United Imaging, Mindray, and ByteDance.

Shenyi Technology embraces a dual-track development strategy that harmonizes "rigorous medical care with consumer health." Recently, the company successfully concluded an angel round of financing exceeding ten million yuan. This round was spearheaded by Leaguer Ventures, with additional investment from Dongguan Biotech. The proceeds from this financing will be channeled into core technology R&D, large-scale production of consumer-grade products, expansion into overseas markets, and clinical validation and regulatory compliance for medical-grade products.

In the medical realm, Shenyi Technology is concentrating on non-invasive, precise deep brain neural modulation. It is constructing a closed-loop diagnosis and treatment system and deploying related technologies and products. On the consumer front, the company leverages miniaturized wearable brain-computer interface products as a gateway, integrating AI technology to facilitate brain state analysis and adaptive intervention.

Shenyi Technology envisions establishing a tiered product system that will seamlessly integrate brain function monitoring and intervention technologies into home and daily life scenarios. Leaguer Ventures, Dongguan Biotech, the National High-Performance Medical Device Innovation Center, and the company's founders have all voiced their confidence in Shenyi Technology's technological prowess, strategic vision, and promising development trajectory.